Pediatric Pharmacy Administrative Group Committee on Pediatric Pharmacy Practice
Pediatric pharmacy practice guidelines. Pediatric Pharmacy Administrative Group Committee on Pediatric Pharmacy Practice
Abstract
Pediatric patients are unique because of age-specific differences in metabolic capacity, disease processes that may make commercially available pharmaceutical preparations unacceptable for use, a lack of published information on the effects of many new pharmacotherapeutic agents in this population, and changes in population demographics caused by new diseases (e.g., AIDS) and new technologic applications. Comprehensive pharmaceutical services are essential for maximizing the benefits--while avoiding or minimizing adverse effects--of pharmacotherapy and new technologies. Comprehensive pharmaceutical services can help maximize the use of health-care resources in the pediatric population and assist in the development, implementation and evaluation of new methods of treatment that will benefit children everywhere.
Source and rights
Published by American journal of hospital pharmacy, 1991. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
At a glance
- Organisation
- Pediatric Pharmacy Administrative Group Committee on Pediatric Pharmacy Practice
- Published
- 1991
- Applies to
- 🇺🇸 United States
- Scope
- National
- Journal
- American journal of hospital pharmacy
- PubMed
- 1746585







